Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4924015

Cc1cc(C)cc(-c2nnc(-c3cccnc3)o2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.57
RAB9A P51151 4/20 0.57
KDM4E B2RXH2 7/20 0.50
MAPK1 P28482 3/20 0.50
HTT P42858 2/20 0.50
POLB P06746 1/20 0.50
HSD17B10 Q99714 3/20 0.47
ALDH1A1 P00352 4/20 0.47
HPGD P15428 3/20 0.47
KMT2A Q03164 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
EGFR P00533 1/20 0.46
PTGS2 P35354 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CA2 P00918 1/20 0.45
CDC7 O00311 1/20 0.45
DBF4 Q9UBU7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3632956 0.91 KDM4E (0.57) NPC1RAB9AKDM4EMAPK1HTT
Trifluoroacetic Acid SCHEMBL4927459 0.89 NPC1 (0.74) NPC1RAB9AKDM4EMAPK1HTT
SCHEMBL1423301 0.87 NPC1 (0.73) NPC1RAB9AKDM4EMAPK1HTT
Trifluoroacetic Acid SCHEMBL3626115 0.86 NPC1 (0.54) NPC1RAB9AKDM4EMAPK1HTT
Trifluoroacetic Acid SCHEMBL3634468 0.85 NPC1 (0.54) NPC1RAB9AKDM4EMAPK1HTT
Trifluoroacetic Acid SCHEMBL4923918 0.85 NPC1 (0.54) NPC1RAB9AKDM4EMAPK1HTT
Trifluoroacetic Acid SCHEMBL3631975 0.85 NPC1 (0.54) NPC1RAB9AKDM4EMAPK1HTT
Trifluoroacetic Acid SCHEMBL3634483 0.85 NPC1 (0.54) NPC1RAB9AKDM4EMAPK1HTT
Trifluoroacetic Acid SCHEMBL3629214 0.84 KDM4E (0.61) NPC1RAB9AKDM4EMAPK1HTT
Trifluoroacetic Acid SCHEMBL4928304 0.84 NPC1 (0.58) NPC1RAB9AKDM4EMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255203-A1 HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE ABBOTT LABORATORIES (US) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255203-A1 HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE CYP11B2, AADAC, CYP11B1 NPC1 473/4885RAB9A 3859/4885KDM4E 3588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.